BIOLASE is taking the necessary steps to optimize operations to capitalize on the rising business momentum for its market-leading dental lasers. The company.

BIOLASE, Inc. (NASDAQ: BIOL) (“BIOLASE” or the “company”), a global leader in dental lasers, announced the pricing of an underwritten public offering of.

BIOLASE announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close of the.

BIOLASE has launched a new e-commerce website for its customers in the United States. The new website, store.biolase.com, combines a state-of-the-art desktop and mobile-friendly.

BIOLASE, Inc. announced that it has been invited to present at the Third Annual Winter Wonderland Best Ideas Virtual Investor Conference being held February.

BIOLASE announced that the company has been awarded a Top Workplaces 2022 honor by the Orange County Register Top Workplaces. The award is.

BIOLASE announced it has been invited to participate in the 11th Annual Benchmark Discovery One-on-One Investor Conference taking place in New York City.

BIOLASE announced its financial results for the third quarter, which ended September 30, 2022. 2022 Third Quarter Highlights Total revenue was $12.0 million,.

BIOLASE announced that it will release third quarter 2022 financial and operating results on Thursday, November 10, 2022 after the close of the U.S. financial.